Based in Toronto, Canada, Serna Bio, formerly known as Ladder Therapeutics, focuses on developing novel therapeutics for diseases with high unmet medical needs by targeting the transcriptome. They utilize an in-silico and in-vitro platform to discover small-molecule RNA modulators, combining machine learning, new chemistry, and RNA biology. Serna Bio is a fast-growing company that aims to improve global health by developing innovative treatments.